With its industry's first all-metal heating and light-sensor technologies, Panasonic's IH appliance allows consumers to measure cooking temperatures so they can accurately control the amount of heat generated for cooking.

As demand increases for products that perform intelligent functions, companies face the challenge of managing complex design environments to interconnect the software, mechanical and electrical components required to manufacture these products. IBM and Dassault Systemes are helping Panasonic's Kitchen Appliance BU use CATIA software, a 3D virtual design platform, for the digital development of product design plans used in the manufacturing of more energy-efficient, electrical appliances.

"Compared to other software design products, CATIA has a rich set of design functions needed for products requiring sophisticated surface and shape designs such as our electric cooking heaters," said Yasushi Morimoto, team leader, Kitchen Appliance BU, Home Appliances Company, Panasonic. "Seamless integration between CAD, CAE (Computer Aided Engineering) and CAM (Computer Aided Manufacturing) drove our decision to choose Dassault Systemes 3D platform. Our goal is to expand into new product development areas by enhancing collaboration among internal units, realizing global collaborative design, and improving perfection of design through expanding utilization of CAE."

"Japanese companies have long mastered the art of achieving excellence in product design and manufacturing and with Dassault Systemes CATIA 3D software, Panasonic's home appliance division can now deliver a smarter and greener product," said Albert Bunshaft, vice president, IBM Product Lifecycle Management.

((Comments on this story may be sent to newsdesk@closeupmedia.com))

Given System z's ability to reduce costs through server consolidation, IBM and the industry have aggressively extended the breadth of new workloads for the mainframe via 3,800 z/OS-based and 3,000 Linux-based applications. The unique ability of the mainframe to host many application services on one system has helped System z achieve one of the industry's lowest application costs per user. Minimal application costs are important for companies which rely on multiple applications to run their business.

About IBM International Business Machines Corporation (IBM) develops and manufactures information technology products and services worldwide.

Advanced Cell Technology Files IND With FDA For First Human Clinical Trial Using Embryonic Stem Cells to Treat Eye Disease

Advanced Cell Technology, Inc. (OTCBB:ACTC) announced today November 19, 2009 filed an Investigational New Drug (IND) Application with the US Food and Drug Administration (FDA) to initiate a Phase I/II multicenter study using embryonic stem cell derived retinal cells to treat patients with Stargardt's Macular Dystrophy (SMD).

As many as 10 million people in the United States have photoreceptor degenerative disease. The treatment for eye disease uses stem cells to re-create a type of cell in the retina that supports the photoreceptors needed for vision. These cells, called retinal pigment epithelium (RPE), are often the first to die off in SMD and AMD, which in turn leads to loss of vision.

About Advanced Cell Technology, Inc.

Advanced Cell Technology, Inc. is a biotechnology company applying cellular technology in the field of regenerative medicine.

Sign up to receive FREE Stock-PR alerts from CRWENewswire.com at http://www.crwenewswire.com/c/stock-pr

About CRWENews.com

CRWENews.com is an independent electronic informative online financial news publication company dedicated in providing company associates, business and financial professionals with economic and investment information, as well as stock highlights. CRWENews.com is a division of Crown Equity Holdings, Inc.

CRWENews.com is not a registered investment advisor or broker-dealer. CRWENews.com and Crown Equity Holdings, Inc., (CRWE) affiliates, officers, directors, contractors and employees, including may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.

We encourage investors to join and receive CRWENews.com FREE e-mail news and stock watch alerts at http://www.crwenewswire.com/c/stock-pr and view our full disclaimer.

Forward-Looking Statement: This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements and/or Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.

CONTACT: Kenneth Bosket, Crown Equity Holdings, Inc e-mail: ccollins@crownequityholdings.com Tel: +1 702 448 1543 Fax: +1 702 258 9007 WWW: http://www.crwenewswire.com

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

The new products span IBM's software portfolio to provide a range of benefits for System z customers. The benefits include optimal application connectivity, productivity, security and data management.

The new offerings complement IBM's recent announcement of seven integrated hardware, software and services packages -- IBM System z Solution Editions -- to help customers deploy new enterprise workloads, such as data warehousing, electronic payments and disaster recovery.

The new products include:

- IMS 11 provides direct SQL access to IMS data from any distributed platform. This simplifies and speeds the process of connecting applications and data, while also enabling easier data replication and change capture processes. Enhanced Java support expands the number of developers available to support IMS applications and business services.

- New products from WebSphere to enhance business process management, connectivity and integration including: WebSphere Process Server for z/OS V7, IBM WebSphere ILOG Business Rule Management Systems, WebSphere MQ for z/OS V7.0.1, WebSphere Message Broker for z/OS V7.0, and IBM Problem Determination Tools V10. These products are designed to help clients discover insights that enable innovation, maximize the value of business interactions, and optimize productivity and resources. For a full list and description of the new WebSphere products visit: www.ibm.com/smartwork/businessagility

To help clients cut application maintenance costs, IBM offers:

- IBM Rational Developer for System z version 7.6 provides a modern GUI development environment, to increase developer productivity and lower the costs associated with maintaining and building multi-platform applications. The new offering helps attract next-generation workers, consolidates multi-language development into a single environment and dramatically reduces CPU usage of up to 50 percent, minimizing budget expenditures.

- IBM Rational Team Concert for System z version 2.0 uses a new common repository to help teams to work together, share assets, automate processes and deliver software faster. The software expedites response times and cuts costs by consolidating disparate development team infrastructures and automating software development across multiple platforms, which is important for tiered applications.

- An enhanced set of IBM Rational Compilers for C/C++, COBOL and PL/I reduce application MIP requirements, while increasing developer productivity and reducing both capital expense and overall development costs.

To help clients gain better insights about enterprise assets and lower network management costs, IBM offers:

- Tivoli Asset Discovery for z/OS removes unused and obsolete software and helps determine software usage to plan effectively for the future and to run smarter systems.

- IBM Tivoli NetView for z/OS 5.4 improves network and automation control for data centers and change management. It provides an understanding of how network availability and events impact the business, helping customers deliver smarter, more automated systems.

- IBM Tivoli zSecure provides a mainframe security solution for automated analysis and reporting of mainframe events and compliance dashboards that lower auditing costs helping companies run a smarter more cost effective system.

Telcordia, Sodifrance and HVB Unicredit are among the companies worldwide already benefiting from the long-term economics of the System z platform.

'Telcordia's data systems are designed to provide consistently high throughput all the time. Each system averages five million transactions per day, supporting an average of 250 gigabytes of active data,' said Paul Gandolfo, a senior technical specialist in application development and performance at Telcordia. 'Our customers bet their businesses on the services we provide, and we bet our service performance and reliability on IBM's Information Management System. Downtime is not an option.'

'Building an agile development team requires a multiplatform approach and Sodifrance uses Rational Developer for System z and Rational Team Concert for System z to help application teams synchronize their efforts and improve collaboration,' said Hugh Smith, project manager of Sodifrance. 'Rational on System z offers a powerful and valuable combination for any company that wants to boost its development team's productivity.'

'Programmers that are using Rational Developer for System z have found that development is more comfortable than with our existing set of development tools,' says Almut Geiger of HVB Unicredit. 'Debugging in particular is much faster. Features like syntax checking, content assist, multiple views and error identification make development easier. For example, when there were coding errors before, a developer had to find the correct line number in the code and then try to determine what was wrong with the code. Now they just click on an icon, and they are led directly to the position of the error. It takes people some time to get familiar with a new environment, but when they become familiar with Rational Developer for System z, we are seeing an estimated 15 percent increase in development efficiency and a 10 percent increase in testing efficiency.'

For more information of System z, visit http://www.ibm.com/mainframe

For more information about System z software, visit http://www.ibm.com/software/os/systemz

CONTACT: Mylissa Tsai, IBM Media Relations Tel: +1 917 472 3680 e-mail: tsaim@us.ibm.com

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

In such a highly-regulated industry, pharmaceutical companies need a 360-degree view of their entire product development and delivery chain in order to best transform reporting information into business insights, and improve a wide range of critical functions. Prior to implementing IBM business analytics technology, Impax Labs was dependent on IT staff to produce critical line of business reports using information that was spread out across the organization. This approach created an overload of information requests that made it difficult for executives and managers to quickly recognize trouble spots or capitalize on new market opportunities. Once the information was delivered, it was usually out of date, and cycles would be spent trying to determine the accuracy of the data.

With IBM business analytics, business users can now build their own reports and analyses instantly, enabling them to quickly identify performance trends and adjust plans accordingly, forecast sales to ensure top and bottom line growth, and provide senior management with the reports they need to effectively manage the overall business.

Today, users across all departments -- including accounting, sales operations, and manufacturing -- have standardized IBM business analytics into their daily routines, optimizing critical functions such as product development, order fulfillment, inventory management, and long-term revenue planning. For instance:

    --  forecast managers can now quickly analyze current and historical product
        inventory levels within an 18-month forecast and shipment history,
        enabling them to proactively manage customer demand and internal
        inventory levels, as well as identify potential supply issues
    --  Sales and marketing executives can track net sales performance against
        corporate plans on a daily basis, granting them immediate visibility
        into whether corrective actions are required, such as negotiating
        specific customer treatments, to improve sales

    --  C-level Executive Committee can now easily pull together a single view
        of net sales, profitability and competitive market share information,
        helping them to determine whether to expand or decrease product
        production

By eliminating IT bottlenecks and empowering business users to manage performance directly, company executives estimate they have saved over a thousand hours per month in time that would normally have been spent chasing and authenticating information.

"We now benefit from quicker access to accurate performance data, which means management has greater confidence in the information and more importantly the decisions they make around resource allocation and overall corporate strategy," said Jonathan Retano, associate director of business intelligence at Impax Laboratories, Inc., who worked with IBM business partner ISA Consulting in developing the company's enterprise-wide business analytics strategy. "Business intelligence and analytics has crossed the threshold from a novelty to an integral, critical part of our business operations."

Using IBM's flexible dashboarding capabilities, Impax Labs also implemented a "4 in 4" program, where senior managers are now able to review the top four performance indicators that are key to their line of business or unit, in under four minutes. This helps them better manage their day-to-day operations and ensure that every decision they make is best aligned with corporate objectives.

Furthermore, the IBM analytics technology empowers Impax Labs to meet internal policy demands and minimize risk exposures. For example, the sales operations department generates comprehensive rebate backup reports that detail every indirect sale by product, wholesaler and pharmacy. This enables them to easily substantiate all customers' rebate requests before they are fulfilled, eliminating the risk of unnecessary cash outflow.

IBM business analytics and optimization is driving new innovation in information management as organizations transform the way they use information to better understand what is going on inside their business.

"Pharmaceutical companies face tremendous costs to support their research, development and sales and marketing initiatives. Effective business analytics solutions can eliminate the typical information blind spots that can interfere with a company's ability to act with speed and agility and make fact-based decisions," said Paul Hake, life sciences executive, business analytics and performance management, at IBM.

About Impax Laboratories, Inc:

Impax Laboratories, Inc. is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products. Impax Labs markets its generic products through its Global Pharmaceuticals division and markets its branded products through the Impax Pharmaceuticals division. Additionally, where strategically appropriate, Impax Labs has developed marketing partnerships to fully leverage its technology platform. Impax Laboratories is headquartered in Hayward, California, and has a full range of capabilities in its Hayward and Philadelphia facilities. For more information, please visit: www.impaxlabs.com.

About IBM:

For more information about IBM Smarter Planet, please visit www.ibm.com/press/smarterplanet.

For more information about IBM Information Management, please visit http://www-01.ibm.com/software/data/.

    Media Contact:
    David DeRosa
    IBM
    613-356-6033
    david.derosa@ca.ibm.com

SOURCE IBM

http://www.ibm.com